MIRA INFORM REPORT

 

 

Report Date :

14.05.2011

 

IDENTIFICATION DETAILS

 

Name :

MAITHRI LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

MSN House, Plot No.C24, Sanath Nagar Industrial Estate, Sanath Nagar, Hyderabad – 500 018, Andhra Pradesh 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

20.03.2002

 

 

Com. Reg. No.:

01-038674

 

 

Capital Investment / Paid-up Capital :

Rs.9.200 millions

 

 

CIN No.:

[Company Identification No.]

U24239AP2002PTC038674

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDM01771A

 

 

PAN No.:

[Permanent Account No.]

AACCM8213E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Bulk Drugs and Organic Intermediates.

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 204000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Latest financials of the company are not available with government department. However, trade relations are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Shrinivasan

Designation :

Financial Head

Contact No.:

91-9848556957

Date :

11.05.2011

 

 

LOCATIONS

 

Registered Office :

MSN House, Plot No.C24, Sanath Nagar Industrial Estate, Sanath Nagar, Hyderabad – 500 018, Andhra Pradesh, India

Tel. No.:

91-40-23816703/ 30438600

Mobile No.:

91-9848556957 (Mr. Shrinivasan)

Fax No.:

91-40-23815713/ 30438638

E-Mail :

chakilamnagaraju@sify.com

maithrilabs@gmail.com

Website :

www.msnlabs.com

Location :

Owned

 

 

Head Office :

115/2RT, 7-1-621/39, Sanjeevareddy Road, Hyderabad – 500 038, Andhra Pradesh, India

Tel. No.:

91-40-23816703

Fax No.:

91-40-23815713

 

 

Factory 1 :

Survey No.14, Gaddapotharam Village, Jinnaram Mandal, Medak District - 502 319, Andhra Pradesh, India

Tel. No.:

91-8458-277090

Fax No.:

91-8458-277085

Area :

84000 sq ft

Location :

Owned

 

 

Factory 2 :

Survey No.317 and 323, Rudraram Village, Patancheru Mandal, Medak District - 502 329, Andhra Pradesh, India

Tel. No.:

91-8455-220372

Fax No.:

91-8458-279938

 

 

DIRECTORS

 

As on 30.09.2010

 

Name :

Mr. Chakilam Naga Raju

Designation :

Managing Director

Address :

Plot 16, Icrisat Colony, Phase – II, Bowenpally, Hyderabad – 500 011, Andhra Pradesh, India

Date of Birth/Age :

01.09.1960

Date of Appointment :

20.03.2002

DIN No.:

01657612

 

 

Name :

Mr. Manne Satyanarayana Reddy

Designation :

Director

Address :

H.No.8-3-167/D/16, Kalyan Nagar, Phase – 1, Near A.G. Colony, R.R. District, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

18.04.1957

Date of Appointment :

19.12.2003

DIN No.:

01657567

 

 

Name :

Mr. Battu Saida Reddy

Designation :

Director

Address :

Flat No.302, Swaroop Apartments, Leela Nagar, Ameerpet, Hyderabad – 500 016, Andhra Pradesh, India

Date of Birth/Age :

01.06.1960

Date of Appointment :

20.03.2002

Date of Ceasing :

31.03.2011

DIN No.:

00277759

 

 

KEY EXECUTIVES

 

Name :

Mr. Shrinivasan

Designation :

Financial Head

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2010

 

Names of Shareholders

 

 

No. of Shares

Battu Saida Reddy

 

4000

Manne Venkat Pratap Reddy

 

10000

Chakilam Naga Raju

 

269500

Manne Satyanarayana Reddy

 

608000

Manne Laxmi Prasuna

 

498000

Chakilam Sujatha

 

30500

Total

 

1420000

 

As on 30.09.2010

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Bulk Drugs and Organic Intermediates.

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

PRODUCTION STATUS (AS ON 31.03.2007)

 

Particulars

Installed Capacity

 

Actual Production

Chemical Intermediates

9,000 MT p.a.

6,239 KGs

 

 

 

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers and End Users

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

State Bank of Hyderabad, Shapur Nagar Branch, Jeedimelta, Hyderabad – 500 055, Andhra Pradesh, India

 

 

Facilities :

Secured Loans

31.03.2007

Rs. In Millions

31.03.2006

Rs. In Millions

State Bank of Hyderabad – WC Loan

45.301

23.570

State Bank of Hyderabad – Term Loan

1.779

2.347

Vehicle loans from commercial banks

2.395

2.370

Total

49.475

28.287

 

Notes:

 

a) Working Capital:

 

The Working Capital Loan from State Bank of Hyderabad are secured by hypothecation of current assets and movable and immovable fixed assets of the company and equitable mortgage of land and buildings of the company and also secured by way of personal guarantee by Managing Director and two other directors of the company.

 

b) Vehicle Loans:

 

Hire Purchase loans are secured by way of hypothecation of respective assets acquired under Hire Purchase Arrangements.

 

Unsecured Loans

31.03.2007

Rs. In Millions

31.03.2006

Rs. In Millions

Unsecured loan from Directors/ Others 

0.000

1.031

Total

0.000

1.031

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

B.R.M. Reddy and Company

Chartered Accountants

Address :

6-3-1186/A/6, II Floor, Behind Blue Moon Hotel, Begumpet, Hyderabad – 500 016, Andhra Pradesh, India

 

 

Group Companies :

v      MSN Laboratories Limited

v      MSN Pharmachem Private Limited

v      MSN Pharmachem Private Limited

 

 

CAPITAL STRUCTURE

 

As on 30.09.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

1500000

Equity Shares

Rs.10/- each

Rs.15.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

1420000

Equity Shares

Rs.10/- each

Rs.14.200 millions

 

 

 

 

 

As on 31.03.2007

 

Authorised Capital :

No. of Shares

Type

Value

Amount

920000

Equity Shares

Rs.10/- each

Rs.9.200 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

920000

Equity Shares

Rs.10/- each

Rs.9.200 millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

9.200

9.200

5.000

2] Share Application Money

1.000

0.000

1.136

3] Reserves & Surplus

40.916

12.974

5.790

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

51.116

22.174

11.926

LOAN FUNDS

 

 

 

1] Secured Loans

49.475

28.287

13.644

2] Unsecured Loans

0.000

1.031

2.082

TOTAL BORROWING

49.475

29.318

15.726

DEFERRED TAX LIABILITIES

0.000

0.000

0.169

 

 

 

 

TOTAL

100.591

51.492

27.821

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

21.229

14.739

14.826

Capital work-in-progress

0.000

1.273

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.300

0.284

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

43.956

30.702

16.733

 

Sundry Debtors

129.225

59.877

32.259

 

Cash & Bank Balances

2.161

1.181

0.060

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

16.631

32.609

8.347

Total Current Assets

191.973

124.369

57.399

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

95.027

85.286

41.759

 

Other Current Liabilities

1.102

0.000

0.000

 

Provisions

16.782

3.910

2.692

Total Current Liabilities

112.911

89.196

44.451

Net Current Assets

79.062

35.173

12.948

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.023

0.047

 

 

 

 

TOTAL

100.591

51.492

27.821

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2007

31.03.2006

31.03.2005

 

SALES

 

 

 

 

 

Income

344.656

197.282

110.255

 

 

Other Income

0.414

0.198

0.188

 

 

TOTAL                                     (A)

345.070

197.480

110.443

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Material Consumed

248.867

155.160

84.242

 

 

Personnel Costs

11.886

5.892

4.497

 

 

Other Manufacturing Expenses

13.297

8.916

6.299

 

 

Administrative & Selling Expenses

34.221

16.117

7.444

 

 

Increase/ Decrease in Stocks

(17.191)

(6.438)

(1.698)

 

 

TOTAL                                     (B)

291.080

179.647

100.784

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

53.990

17.833

9.659

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

5.667

3.036

1.187

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

48.323

14.797

8.472

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

3.448

3.831

3.207

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

44.875

10.966

5.265

 

 

 

 

 

Less

TAX                                                                  (H)

16.933

3.782

3.070

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

27.942

7.184

2.195

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

12.974

5.790

3.595

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

40.916

12.974

5.790

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

94.472

33.245

10.862

 

TOTAL EARNINGS

94.472

33.245

10.862

 

 

 

 

 

 

Earnings Per Share (Rs.)

30.37

14.33

NA

 

Particulars

 

 

 

31.03.2011

(Approximately)

Sales Turnover

 

 

520.000

 

The above information has been parted by Mr. Shrinivasan (Financial Head).

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

8.10

3.64

1.99

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

13.02

5.56

4.78

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

21.05

7.88

7.29

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.88

0.49

0.44

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

3.18

5.34

5.05

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.70

1.39

1.29

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Note:

The registered office of the company has been shifted from Flat.No.302, Swaroop Apartments, Leela Nagar, Ameerpet, Hyderabad - 500 016, Andhra Pradesh to the present address w.e.f. 28.09.2009.

 

FINANCIAL PERFORMANCE:

 

For the year the company recorded gross sales of Rs.369.400 millions in the FY 07 as against Rs.217.800 millions in the FY 06, an increase of over 69.67%. Operating margins were 16.36% in FY 07 as against 9.04% in FY 06 Net profits as a percentage of net sales was 8.47% as against 3.64% during the previous year.

 

Material costs decreased to 75.41% of net sales as against 78.65% during the previous year. This was due to improvement made to the production processes through continuous process research and development activities undertaken by the company introduction of new products as also increased revenues from the products launched during the previous year.

 

Inspite of absolute increase in operating and other expenses the operating profits (EBIDTA) of the company as percentage to net sales was 16.36 % in FY 07 as against 9.03% in FY 06. This was mainly due to process improvements through research and development product mix and better supply chain management. Profit after tax (PAT) also increased to 8.47% of net sales as against 3.64% during the previous year. 

 

OPERATIONS:

 

The company presently has one world class manufacturing facility situated at Gaddapotharam Village. Jinnaram Mandal, Medak District, Near Hyderabad. The company produces around final products- APIs in this facility in addition to other chemicals and intermediates. Of this the major products are atorvastatin, moxifloxacin, Telmisartan which together contribute around 52% of the product revenues.

 

FORM 8:

 

This form is for

Modification of charge

Charge identification number of the modified 

 

Corporate identity number of the company

U24239AP2002PTC038674

Name of the company

MAITHRI LABORATORIES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Flat.No.302, Swaroop Apartments, Leela Nagar, Ameerpet, Hyderabad - 500 016, Andhra Pradesh, India

Type of charge

Immovable Property

Book Debts

Movable Property

Particular of charge holder

State Bank of Hyderabad, Shapur Nagar Branch, Jeedimelta, Hyderabad – 500 055, Andhra Pradesh, India

E-Mail: hyd_sbhshapur@sanchar.net.in

Nature of description of the instrument creating or modifying the charge

Supplemental agreement of loan for increase in overall limits - C1-A

Supplemental agreement of hypothecation of goods and assets - C2-A

Supplemental deed of guarantee for increase in overall limits - C4-A

Letter regarding individual limits within overall limits - C5

Date of instrument Creating the charge

27/06/2007

Amount secured by the charge

Rs.104.000 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

Interest at 12.50% per annum

 

Terms of Repayment:

Working Capital - on demand

term loans to be repaid in 12 quarterly installments commencing from 1st April, 2008

 

Margin:

Stocks - 25%

Book debts - 50%

Term loan (land and buildings/ plant and machinery) - 33.33%

 

Extent and Operation of the charge:

The charge operates as security for the total repayment of all loans - working capital and term loans - and non fund based facilities of BG and LC, along with interest, penal interest and other charges.

 

Others:

Personal guarantees of directors - Sri Ch. Nagaraju, Sri B. Saida Reddy, Sri MSN Reddy, Smt. B. Chandra Kala, Sri C. Janardhan Reddy. Corporate Guarantees of MSN Laboratories Limited, and MSN Pharmachem Private Limited.

Short particulars of the property charged

Hypothecation of goods/stocks/raw materials created out of bank funds counter indemnity / guarantees for bank guarantees.

E.M. of (1) factory land and buildings in Sy. No.14, Gaddapotharam Village, Jinnaram M, Medak District.

(2) Residential Flat No. 302, Iii Floor, Ameerpet, Hyderabad of Smt B. Chandrakala.

(3)Open Plot No 10, Sy. No. 22 to 30, 47, 9, 49, 300 and 303

(4)Plot 167 and 168, Sy. No.121, 127 and 128, Vinayakanagar of Sri MSN Reddy

(5)Open Plot No 113, 450 Sq yds In Sy. No.100, 101 and 105, Block 49, Padmanagar Colony.

Date of latest modification prior to the present modification

17/03/2007

Particulars of the present modification 

Overall Limits Increased From Rs.100.000 millions to Rs.104.000 millions --

Cash Credit Hypothecation Rs.60.000 millions

(Sublimit for CCPC Rs.33.000 millions, Sublimit for FUBD Rs.33.000 millions),

Term Loan-I Rs.4.000 millions,

Term Loan-Ii Rs.15.000 millions

Letter Of Credit Rs.20.000 millions

Bank Guarantee Rs.5.000 millions

Aggregate – Rs.104.000 millions

 

CONTINGENT LIABILITIES ON ACCOUNT OF:

 

Particulars

31.03.2007

(Rs. in millions)

Letter of Credit

4.011

Bank Guarantee

4.178

Corporate Guarantee

75.500

 

 

 

FIXED ASSETS:

 

v      Buildings

v      Compound Wall

v      Land and Site Development

v      Office Equipment

v      Plant and Machinery

v      Computer

v      Furniture and Fixtures

v      Motor Vehicle

v      Electrical Fittings

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.91

UK Pound

1

Rs.73.05

Euro

1

Rs.64.03

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.